| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |